Viewing Study NCT02951533


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-03-02 @ 10:34 PM
Study NCT ID: NCT02951533
Status: COMPLETED
Last Update Posted: 2020-02-28
First Post: 2016-10-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Sponsor: Janssen-Cilag G.m.b.H
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR108220
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators